Pharmaceuticals Market Reports

Global Fatty Acid Oxidation Disorder Market Size, Trends, and Analysis - Forecasts To 2026 By Drug Type (Levocarnitine, Dextrose, Riboflavin, and Others), By Route of Administration (Oral and Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Stores), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis

The overall population is expected to reach 8.5 billion by 2030, leading to an increase in the worldwide consumption of numerous products. Expanding need for sustainable bio-products including soaps, food emulsifiers, surface cleaners, detergents, fertilizers, cosmetics, paints, and skincare items has raised the fatty acid market requirement for industrial commercial, and consumer use. Read More »
June 9 : 2021

Global Bipolar Disorder Market Size, Trends & Analysis - Forecasts to 2026 By Mechanism of Action (Benzodiazepines, Selective serotonin reuptake inhibitor, Serotonin-norepinephrine reuptake inhibitor, Tricyclic antidepressant drugs, Monoamine oxidase inhibitors, Beta-blockers, Others) By Drug Class (Antidepressant drugs, Mood stabilizer, Anticonvulsants, Antianxiety drugs, Antipsychotic drugs) By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis

In the projected period, technological developments and the acceptance of a sedentary lifestyle are anticipated to propel the growth of the bipolar disorder treatment market. Also, expanding factors such as genetics and the environment may affect brain structure and chemistry, leading to the development of bipolar illnesses, which would enhance numerous prospects, resulting in the growth of the bipolar disorder treatment market over the projection period. Read More »
June 4 : 2021

Global Gaucher Disease Drugs Market Size, Trends, and Analysis - Forecasts To 2026 By Type (Type 1, Type 2, Type 3), By Therapy (Enzyme Replacement Therapy, Substrate Replacement Therapy) By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis

Gaucher disease/disorder is a hereditary and genetic disorder in which fatty molecules build up in the cells or tissues. Constant fatigue, a swollen spleen, anemia, liver, and skin bruising, and a reduced blood cholesterol level are all common symptoms of genetic disorders. Read More »
June 4 : 2021

Global Erythropoietin Drugs Market Size, Trends & Analysis - Forecasts to 2026 By Application (Renal Diseases, Cancer, Neurology, Hematology), By Drugs Class (Biosimilars, Biologics), By Product (Darbepoetin-alfa, Epoetin-alfa, Epoetin-beta, Others), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis

The hormone erythropoietin (EPO), also known as haemopoietin, is produced endogenously by the kidneys and plays an important role in the generation of red blood cells (RBCs). Red platelets are formed in the bone marrow and aid in the transport of oxygen throughout the body. Read More »
June 2 : 2021

Global Nasal Spray For Covid-19 Market Size, Trends & Analysis - Forecasts to 2026 By Offering (Vaccine, Off-Load Viral, Others), By End-Use (Hospital, Clinics, Home Care Settings, Others ), By Region (North America, Asia Pacific, Europe, Latin America, Middle East & Africa); End-User Landscape, Company Market Share Analysis, and Competitor Analysis

Increasing urgency to control the community transmission of the virus along with the need to introduce products that can reduce the burden on hospitals and clinics is stimulating the market growth. As it is also noticed that hospitals and clinics are the major hotspots to transmit the virus, thus, the introduction of these viral relieving products will curb the virus load of the surroundings. Read More »
June 2 : 2021

Global Cystic Fibrosis Therapeutics Market Size, Trends & Analysis - Forecasts to 2026 By Drug Class (Pancreatic Enzyme Supplements, Mucolytics, Bronchodilators, CFTR Modulators), By Route of Administration (Oral drugs, Inhaled drugs), By Region (North America, Asia Pacific, CSA, Europe, and The Middle East and Africa); End-User, Landscape, Company Market Share Analysis, and Competitor Analysis

Mucoviscidosis often referred to as cystic fibrosis, is a hereditary condition that is characterized by improper sodium and chloride transport through an epithelium, resulting in a lung infection that impairs breathing. Cystic fibrosis makes serious harm to the respiratory and stomach system. Read More »
May 26 : 2021